A Phase 3 study in late-line colorectal cancer.
Latest Information Update: 28 Oct 2025
At a glance
- Drugs IBI 363 (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
Most Recent Events
- 28 Oct 2025 New trial record
Latest Information Update: 28 Oct 2025